# Catalys Pacific, LLC: Form 13F holdings

An institutional investment manager in TOKYO. SEC CIK 2011385.

- Quarter ended: 2026-06-30
- Filed: 2026-08-05
- Reported value: $229.5m
- Positions: 2 (2 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2011385/000110465926090867/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [Mineralys Therapeutics, Inc. (MLYS)](/companies/mlys.md) | COM | $213.2m | 92.9% | 7,903,838 |  | Unchanged |
| [Phathom Pharmaceuticals, Inc. (PHAT)](/companies/phat.md) | COM | $16.2m | 7.1% | 1,493,854 |  | Unchanged |

Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-090867. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.